All you need to get started with ETF selection and analysis. Create your account now →
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
CHCL.B ETF · CI Global Healthcare Leaders Index ETF
The CHCL.B Exchange Traded Fund (ETF) is provided by CI. It is built to track an index: Solactive Developed Markets Healthcare 150 CAD Index. The CHCL.B ETF provides physical exposure, so by buying it you actually own parts of all the 151 underlying holdings. This share class generates a stream of income by distributing dividends.
Last update Yesterday at 1:30 PM UTC
LIVE
CLOSED
This fund is part ofWorld Health Care1M perf.-5.33%
Last price
$23.55
1M perf.
-5.03%
1M flows
-€2.3M
AuM
€52M
E/R
0.37%
Rating
Not rated
ESG Consensus®
CHCL.B
$23.55
Performance & flows
Segment for quartile rank
December 12, 2025 → March 12, 2026
Create a free account to view the flows graph
CHCL.B
$23.49
-3.16%
World Health Care
-2.29%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -5.03%  | -3.16%  | +0.86% | +23.09% | N/A | -6.92% | -3.53% | -3.53%  | |
| Flows |
Key fund info
Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) ·
Main characteristics
More details
NAV
3/12/2026
$23.48
1D NAV change
-1.54%
Dividend policy
Replication method
Direct (Physical)
Replication model
Optimized sampling
No. of holdings
151
Inception date
8/17/2021
Jurisdiction
Canada
Distribution
Canada
Legal structure
Open-end Fund
Base currency
CAD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Product type
Benchmark
Solactive Developed Markets Healthcare 150 CAD Index
Asset class
Factors
N/A
Investment strategy
The ETF seeks to replicate, to the extent reasonably possible, the performance of a global healthcare index, net of expenses. Currently, the ETF seeks to replicate the performance of the Solactive Developed Markets Healthcare 150 CAD Index (CA NTR) (the "Index"). The Index intends to track the performance of the largest 150 companies from the global healthcare industry.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSimilar ETFs in your region
XDWH
1M perf.
-5.24%
E/R
0.25%
WHEA
1M perf.
-5.25%
E/R
0.3%
IXJ
1M perf.
-5.34%
E/R
0.4%
IXJ
1M perf.
-4.74%
E/R
0.47%
XHC
1M perf.
-4.64%
E/R
0.66%
Advertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -3.16% | +0.86% | +23.09% | N/A |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
USA
70.02%
Switzerland
9.26%
United Kingdom
5.43%
Japan
3.77%
Denmark
2.55%
France
2.35%
Ireland
1.97%
Germany
1.48%
Unavailable
0.14%
Other
3.04%
Sectors
Health Care
93.18%
Consumer Discretionary
1.06%
Unavailable
4.81%
Other
0.96%
Diversification
Total weight of top 15 holdings out of 151
Top 15 holdings
Data as of January 31, 2026
LILLY
JOHNSON&JOHNSON
ABBVIE
ROCHE
NOVARTIS
ASTRAZENECA
MERCK & CO INC
UNITEDHEALTH GRP
Create a free account to view top holdings
THERMO FISHER SCIENTIFIC
ABBOTT LABS
DK0062498333
AMGEN-T
INTUITIVE SURGICAL
GILEAD SCIENCES
PFIZER
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
No
SDG
ESG Consensus® by Conser
Data as of December 31, 2025
MethodologyOur partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about CHCL.B ETF's sustainability, based on their methodology.
ESG Consensus®
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
CHCL.B’s has a Final Sustainability Grade of either A+, A, or A-.
A+
A
A-
B+
B
B-
C+
C
C-
D
This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight EnterpriseHoldings review
92.06% of holdings have positive scoring
8.08% of holdings have negative scoring
6.08%
69.14%
16.84%
6.34%
Consensus levels
Strong
Medium
Weak
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
CI
CI ID Card
Number of funds
148
Total AuM
€15.06B
Expense ratio range
0.05% - 2.35%
Average expense ratio
0.64%
Top 5 funds by CI
| AuM | ||
|---|---|---|
CSAV | CI First Asset High Interest Savings ETF | €3.14B |
WXM | CI Morningstar Canada Momentum Index ETF | €904M |
CIAI | CI Global Artificial Intelligence ETF | €643M |
DGRC | CI Canada Quality Dividend Growth Index ETF | €534M |
CGSB | CI Global Short-Term Bond Fund | €501M |
Frequently asked questions about CHCL.B
What does CI Global Healthcare Leaders Index ETF, CHCL.B, invest in?
CHCL.B is a Passive ETF. This ETF provides exposure to Developed markets Health Care Equities.
Which benchmark or index does CHCL.B replicate?
CHCL.B tracks the Solactive Developed Markets Healthcare 150 CAD Index (CA NTR) - CAD, through a optimized sampling replication method.
What is the Total Expense ratio (TER) of CHCL.B?
CHCL.B carries a total expense ratio (TER) of 0.37%, indicating the annual cost for holding the fund.
When was CHCL.B launched?
CHCL.B was introduced to the market on August 17, 2021. It trades on Canada
Who is the ETF issuer of CHCL.B?
CI Global Healthcare Leaders Index ETF, CHCL.B, is provided by CI. Learn more about CI here.
What is the current assets under management (AUM) of CHCL.B?
CHCL.B oversees €52M in assets as of March 12, 2026.
How has CHCL.B performed lately?
Based on data from March 12, 2026, CHCL.B returned -5.03% over the past month, -3.16% over the last three months and -3.53% year-to-date.
What are the latest inflows or outflows for CHCL.B?
As of March 12, 2026, CHCL.B recorded net flows of -€2.3M over the last month and -€2.7M year-to-date.
Does CHCL.B distribute dividends?
CHCL.B follows a distributing dividend policy, meaning it pays out income to investors. As of March 12, 2026, its 12-month trailing yield was 1.44%.
What are the main country or region exposures of CHCL.B?
As of January 31, 2026, CHCL.B has significant geographic allocations in USA, Switzerland and United Kingdom.
In which sector or theme does CHCL.B invest in?
As of January 31, 2026, CHCL.B focuses largely on Health Care and Consumer Discretionary.
How many securities does CHCL.B hold and how diversified is it?
As of January 31, 2026, CHCL.B holds 151 positions in its portfolio, with 53.14% of assets concentrated in its top 15 holdings.
What are the main positions in CHCL.B?
As of January 31, 2026, CHCL.B top three holdings include LILLY, JOHNSON&JOHNSON and ABBVIE.
What is the base currency of CHCL.B?
The base currency of CHCL.B is CAD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
